Ponatinib - Frontline for Chronic Myeloid Leukemia (CML) in Accelerated Phase (AP)
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Gruppo Italiano Malattie EMatologiche dell'Adulto
Institute of Hematology and Blood Transfusion, Czech Republic
OHSU Knight Cancer Institute
GWT-TUD GmbH
Takeda
OHSU Knight Cancer Institute
National Institutes of Health Clinical Center (CC)
Dana-Farber Cancer Institute
Ariad Pharmaceuticals